Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications

BACKGROUND: The aim of this paper is to contribute to the discussion on how to approach patients taking new orally administered anticoagulants (NOAs) dabigatran etexilate (a direct thrombin inhibitor), rivaroxaban and apixaban (factor Xa inhibitors), before, during and after dental treatment in ligh...

Descripción completa

Detalles Bibliográficos
Autores principales: Costantinides, Fulvia, Rizzo, Roberto, Pascazio, Lorenzo, Maglione, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731944/
https://www.ncbi.nlm.nih.gov/pubmed/26822674
http://dx.doi.org/10.1186/s12903-016-0170-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731944/
https://www.ncbi.nlm.nih.gov/pubmed/26822674
http://dx.doi.org/10.1186/s12903-016-0170-7

Ejemplares similares